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Molecular charge influences transperitoneal macromolecule
transport
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Molecular charge influences transperitoneal macromolecule transport.
The influence of molecular charge on macromolecule transport during
peritoneal dialysis was assessed by determining transperitoneal trans-
port rates for fluorescent-labeled macromolecules (molecular radii from
15 to 40 A) that differed only in molecular charge: neutral dextran,
anionic dextran sulfate and cationic diethylaminoethyl (DEAE) dex-
tran. The test macromolecules were infused into the bloodstream of
unanesthetized New Zealand White rabbits at a constant rate, and
isotonic dialysis solution (40 mI/kg) was instilled into the peritoneal
cavity. Blood and dialysate samples were taken hourly over a four hour
dwell. Transpentoneal transport rates were assessed by calculating
both the dialysate to plasma concentration ratio at four hours and the
permeability-area product for the peritoneum, the latter parameter
determined from the increase in the dialysate concentration with time.
Transport rates for DEAE dextran were less (P < 0.05) than those for
both neutral dextran and dextran sulfate; transport rates for neutral
dextran and dextran sulfate were not different. Moreover, transperito-
neal transport rates for fluorescent-labeled DEAE dextran were not
affected by adding unlabeled DEAE dextran to the intravenous infusion
solution, an observation suggesting that low transport rates for DEAE
dextran were not due to its binding to plasma protein. We conclude that
molecular charge is a determinant of transpentoneal macromolecule
transport.
Peritoneal dialysis is increasingly employed in the treatment
of end-stage renal disease [1]. A major concern with the chronic
use of peritoneal dialysis is the significant loss of protein into
the dialysis solution that routinely occurs [2, 3]. Proteins that
are lost during peritoneal dialysis originate primarily from the
vascular pool [3]; thus, mechanisms governing peritoneal trans-
port of macromolecules likely reflect general physiological
principles of transport within the microcirculation. Previous
studies have demonstrated that the major factors influencing
macromolecule transport within the microcirculation are mo-
lecular size, hemodynamic conditions, molecular charge, and
molecular configuration [4].
Previous work has demonstrated that transperitoneal solute
transport rates decrease with increasing molecular size and can
be altered when employing dialysis solutions of different tonic-
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ity [5]. The effects of molecular charge and configuration have
not, however, been extensively studied. Molecular charge
might be expected to significantly influence transperitoneal
solute transport since recent anatomical studies have identified
an abundance of negative surface charge on mesenteric endo-
thelial cells, adjacent basement membranes and peritoneal
mesothelial cells [6—8].
The present studies were designed to examine the role of
molecular charge on transperitoneal transport of macromole-
cules in a rabbit model of peritoneal dialysis. The test macro-
molecules employed in these studies were fluorescent-labeled,
polydisperse dextran fractions that differed only in molecular
charge.
Methods
Fluorescent-labeled dextran preparation
Neutral dextran fractions Tb, weight-averaged molecular
weight ——10,000 (Pharmacia Fine Chemicals, Piscataway, New
Jersey, USA), and T2000, average molecular weight —2,000,000
(Sigma Chemical, St. Louis, Missouri, USA), were labeled with
5-fluorescein isothiocyanate (FITC; Eastman Kodak, Roches-
ter, New York, USA) using the method of de Belder and
Granath [9].
High molecular weight fractions of dextran sulfate, —500,000
(Pharmacia), and DEAE dextran, —500,000 (Pharmacia), were
first hydrolyzed by heating in 1 N HC1 at 100°C for 10 to 25
minutes. Hydrolyzed fractions of dextran sulfate and DEAE
dextran were employed in these studies since they had a
comparable molecular weight distribution to the neutral dextran
fraction Tb. Since dextran sulfate and DEAE dextran were
essentially insoluble in dimethyl sulfoxide, the alternative la-
beling procedure of de Belder and Granath [9] using the
fluorescein analog 5-(4,6-dichlorotriazin-2-yl)-amino fluorescein
hydrochloride (DTAF; Eastman Kodak) was employed.
Briefly, 200 mg of DTAF were reacted in water with I g of either
hydrolyzed dextran sulfate or hydrolyzed DEAE dextran for
two hours at pH 12. The unreacted label was separated from the
fluorescent-labeled macromolecules by precipitation with cold
ethanol followed by membrane dialysis using Spectralpor tub-
ing (molecular wt cutoff for protein of 12,000 to 14,000; Spec-
trum Medical, Los Angeles, California, USA) for more than 48
hours. The fluorescent yield of DTAF-labeled dexti-an sulfate
and DEAE dextran was comparable to that of FITC-labeled
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neutral dextran. The degree of substitution of the fluorescent-
labeled macromolecules was not characterized nor was it
critical since only relative fluorescence values were employed
in subsequent calculations. It has been previously shown that
the fluorescent properties of FITC, DTAF and their conjugated
products are virtually identical [10].
The net charge on the fluorescent-labeled dextran fractions
was characterized by observing their binding to ion exchange
columns prepared from DEAE-Sephadex (anion exchanger
A25; Pharmacia) and SP-Sephadex (cationic exchanger C25;
Pharrnacia). DTAF-labeled dextran sulfate was found to bind to
DEAE-Sephadex but not to SP-Sephadex. DTAF-labeled
DEAE dextran was found to bind to SP-Sephadex; moreover,
trace quantities were also observed to bind to DEAE-Sepha-
dex. DTAF-labeled DEAE dextran that had been filtered
through one DEAE-Sephadex column showed no significant
binding upon second passage through a DEAE-Sephadex col-
umn; this filtered preparation was used in certain experiments
to examine the influence of residual anionic components on the
experimental results (see below). FITC-labeled neutral dextran
was not observed to bind to either ion exchanger.
In vivo experiments
Male New Zealand White rabbits, body weight ranging from
2.2 to 3.6 kg, were fasted overnight and anesthetized with
halothane during the surgical procedure. The animals were
placed supine on a heating pad and an indwelling Foley catheter
was passed into the bladder. Following a ventral neck incision,
the carotid artery and jugular vein were cannulated for blood
sampling and the infusion of solutions, respectively. These
cannulas were exteriorized and taped to the skin to allow access
to them during the experiment. A one inch incision in the skin
and through the first layer of muscle of the right lumbar region
was required for insertion of the peritoneal catheter (Sil-Med
Corporation, Taunton, Massachusetts, USA) using a trocar.
The peritoneal catheter was secured into position with a purse-
string suture. After catheter placement, the anesthetic was
turned off and the rabbit was given pure oxygen until conscious-
ness was regained.
After surgery was completed, a 90-minute washout exchange
of the peritoneal cavity using Normosol R (Abbott Laborato-
ries, North Chicago, Illinois, USA) was performed (40 mIkg).
Normosol R solutions had a pH of approximately 6.8 and
contained 140 mEq/liter sodium, 5 mEq/liter potassium, 3
mEq/liter magnesium, 98 mEq/liter chloride, 27 mEq/liter ace-
tate and 23 mEq/liter gluconate. At the beginning of this
washout exchange a baseline arterial blood sample was taken
and a priming dose of test solutes, consisting of 90 mg of
creatinine (Sigma) and 20 mg of a fluorescent-labeled dextran
fraction dissolved in 20 ml of a 0.9% NaCl solution, was then
infused into the animal over a five minute interval. This was
followed by a constant intravenous infusion of a solution
containing the corresponding solutes to maintain their plasma
concentrations relatively constant. After 90 minutes the perito-
neal cavity was drained by gravity as completely as possible
and the experiment was initiated.
Isotonic dialysis solution (Normosol R plus 0.5% glucose)
containing 10 sg/ml of FITC-labeled dextran T2000 was
warmed to 37°C and instilled into the peritoneal cavity (40
mllkg) immediately following drainage of the washout cx-
change. This solution was employed instead of commercial
isotonic peritoneal dialysis solutions since the latter are hyper-
tonic to rabbit plasma. A 1 ml dialysate sample was taken five
minutes after dialysate infusion was completed and then hourly
over a four hour dwell. A 2 ml arterial blood sample was
obtained concomitantly with each dialysate collection. After
the four hour samples had been taken, the peritoneal cavity was
drained as completely as possible. Following drainage, 30 ml of
Normosol R solution were instilled into the peritoneal cavity.
The contents of the peritoneal cavity were mixed for three
minutes and an aliquot of this solution was collected for
calculation of the residual volume of dialysis solution remaining
in the peritoneal cavity. Urine output was collected and moni-
tored throughout each experiment; output in excess of the
infusion volume was replaced volume for volume with a solu-
tion containing 0.45% NaC1 and 2.5% glucose. The experiment
was terminated by a barbiturate overdose.
Twenty-seven experiments were performed in total. The
protocol for each experiment was identical except for the
dextran fractions infused into the bloodstream. Six experiments
were performed using FITC-labeled neutral dextran, five were
performed using DTAF-labeled dextran sulfate, and six were
performed using DTAF-labeled DEAE dextran. Seven addi-
tional experiments were performed using DTAF-labeled DEAE
dextran; three of these used the preparation of DTAF-labeled
DEAE dextran that had been filtered through an anionic ex-
change column to remove residual anionic components (see
above) and the remaining four added unlabeled DEAE dextran
at a concentration approximately sevenfold that of DTAF-
labeled DEAE dextran to the intravenous infusion solution.
Three additional experiments were also performed with FITC-
labeled neutral dextran in the presence of unlabeled dextran
Tb. The concentration of unlabeled dextran Tl0 employed in
these experiments was comparable to that used previously [11].
In vitro experiments
To assess the validity of fluorescent-labeled dextrans as test
macromolecules for investigating transperitoneal transport, in
vitro membrane transport studies using fluorescent-labeled dcx-
trans were performed and were compared with those using
unlabeled dextrans. In vitro experiments were performed on
commercial hemodialyzers containing polysulfone membranes
of high hydraulic permeability (F60 hemodialyzers, Fresenius,
Bad Homburg, Germany). The device was studied in a postdi-
lutional hemofiltration circuit described previously [12]. Sieving
coefficients were determined at perfusate flow rates of 150 and
400 ml/min with an ultrafiltration rate of 60 mllmin. The
perfusate solution was prepared by dilution of commercial
dialysate concentrate (Renalab RL5O, Irvine, California, USA).
The solution reservoir was continuously maintained at 37°C
throughout the experiment.
Sieving coefficients were calculated to assess transmembrane
transport and were determined by concentrations in the input,
output and ultrafiltrate streams as described previously [12].
Sieving coefficients were relatively independent of perfusate
flow rate; the mean value of these determinations was therefore
used. Nine in vitro experiments were performed in total. Three
replicates were performed using the following test solutes:
unlabeled neutral dextran, unlabeled DEAE dextran, and
DTAF-labeled DEAE dextran.
R = 0.305M°47
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Calculations
(2)
Analytical techniques
A molecular weight characterization of unlabeled dextrans
was performed on each relevant sample using high performance The dialysate concentration for all test solutes increased
size exclusion (gel permeation) chromatography [12]. Size continuously with time during an exchange; the increase in
exclusion chromatography was performed using a TSK- dialysate concentration relative to that in plasma was more
G4000PW column with a column buffer containing 0.15 M rapid for smaller solutes. Transperitoneal solute transport was
ammonium acetate and 0.05 M sodium phosphate, pH 6.5. A assessed using two different approaches. First, total overall
Waters Model R401 differential refractometer was employed for transport was assessed simply by calculating the dialysate to
monitoring concentration changes in the column effluent. Col- plasma concentration ratio at the end of the exchange (at 4
umn calibration was performed with dextran standards of very hours). During an isotonic exchange, this measure of solute
low polydispersity [13], and the concentration of unlabeled transport is independent of dialysate volume measurements as a
dextran was determined at appropriate retention volumes as function of time but depends on both the initial volume of
determined from column calibration, isotonic dialysis solution and the length of the dwell. The
No sample preparation was necessary for the analysis of second approach was to calculate the permeability-area product
unlabeled dextran concentrations in the in vitro experiments; (PA) from the change in the dialysate concentration and volume
samples were injected directly onto the column. For in vivo with time during an exchange [11]. During an isotonic ex-
experiments using unlabeled DEAE dextran, no attempt was change, where convective solute transport may be assumed
made to analyze their concentrations. For in vivo experiments
using unlabeled neutral dextran, plasma and dialysate samples
were prepared for chromatographic analysis by procedures
described previously [11].
negligible, the change in the dialysate concentration between
any two times points, t1 and t2, is described by the following
equation [11]
A molecular weight characterization of fluorescent-labeled
dextrans in each sample was also performed using previously
reported methods [14]. Size exclusion chromatography was
PAC 1 PAC
Cd(t2) = [Cd(tl) — PA I[V(t2)/V(ti)V' +
PAIq) +
+ qj PA + q
performed using a TSK-G4000PW column with a column buffer
containing 1.0 M ammonium acetate and 0.05 M sodium phos-
phate, pH 9.0. A Waters Model 420-E fluorescence detector
where Cd denotes the dialysate concentration at the corre-
sponding time points and C, denotes the plasma concentration
was employed for monitoring changes in fluorescence in the (assumed constant). The value of PA has units of volume per
column effluent, with excitation at 450 nm (bandpass filter) and time (comparable to clearance) and is a measure of the
fluorescence at 500 nm (cutoff filter) being monitored. Column transperitoneal solute transport rate that is independent of
calibration was performed with FITC-labeled dextran standards dwell time. Values of PA were estimated for each experiment
of very low polydispersity [13]. FITC-labeled dextran T2000 by comparing the experimental data with equation (2) using
concentration was taken as the relative height of the chromato- nonlinear regression [11].
gram at the column void volume, and the concentration of The actual or true volume of dialysis solution in the perito-
dextran at all other molecular weights was determined at neal cavity as a function of time is difficult to estimate accu-
appropriate retention volumes as determined from column rately. It has been previously shown that the single estimate of
calibration. dialysate volume V to employ when using equation (2) to obtain
Samples analyzed for fluorescent-labeled dextrans were in- the most accurate estimate of PA is that obtained using indica-
jected directly onto the column with no sample preparation. In tor dilution methods [17]. Therefore, changes in dialysate
the experiments employing FITC-labeled and unlabeled neutral volume with time were calculated from changes in the concen-
dextran, isolation of FITC-labeled neutral dextran from each tration of FITC-labeled dextran T2000 in the dialysis solution
sample was performed as described previously [11]. The plasma [11, 18]. For these calculations, no correction was made for loss
concentration of dextran was determined as the fluorescence in of the marker macromolecule from the peritoneal cavity. It
the sample minus the background fluorescence measured in the should be emphasized that this calculated volume is not an
baseline arterial plasma sample. accurate estimate of the actual volume of dialysis solution
The molecular radius (R) of both unlabeled and fluorescent- within the peritoneal cavity. The value of q in equation (2) is the
labeled neutral dextrans in A was computed from previously transperitoneal ultrafiltration rate and was calculated from
reported data [15, 16] by the following equation sequential indicator dilution estimates of dialysate volume [11,
18].
The residual volume remaining after gravity drainage of the
where M denotes neutral dextran molecular weight. Molecular peritoneal cavity was determined from the decrease in FITC-
radii for charged and neutral dextrans were assumed to be equal labeled dextran T2000 concentration following instillation of 30
if they had the same column retention volume. ml of Normosol R solution at the end of the four-hour experi-
Creatinine concentrations were measured by an automated mental exchange. The final true volume of dialysis solution
Jaffè rate methodology (Creatinine Analyzer 2, Beckman In- remaining in the peritoneal cavity at the end of the exchange
struments, Fullerton, California, USA). Glucose concentra- was calculated as the sum of the volume drained and the
tions were measured by a YSI Model 27 Industrial Analyzer calculated residual volume. Fluid absorption rates from the
(Yellow Springs Instrument, Yellow Springs, Ohio, USA). peritoneal cavity were calculated as the difference between
Each concentration of creatinine was corrected for the concen- the indicator dilution volume at the end of the exchange minus
tration of glucose. the final true volume divided by dwell time.
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Dwell time
hr Method Volume
0
1
2
3
4
4
Indicator dilution 109 4
Indicator dilution 125 5
Indicator dilution 127 5
Indicator dilution 130 7
Indicator dilution 132 7
Drain + residual 61 7
Table 2. Dialysate to plasma concentration ratios for creatinine
(mean SEM)
Dwell time
hr Neutral dextran DEAE dextran Dextran sulfate
0
1
2
3
4
0.08 0.01 0.05 0.02 0.05 0.01
0.62 0.04 0.55 0.06 0.62 0.04
0.89 0.04 0.75 0.07 0.78 0.08
1.04 0.05 0.92 0.05 0.86 0.10
1.04 0.02 0.99 0.05 1.04 0.10
Statistics
All experimental values are expressed as the mean the
standard error of the mean (sEM). Statistical significance of
differences between study groups was assessed using single
classification analysis of variance [19]. Individual group differ-
ences were further analyzed by Student's t-test for unpaired
samples with modified confidence limits computed by the
Dunn-Sidák method [19]. Differences were considered statisti-
cally significant at the 0.05 level.
Results
Dialysate volume measurements were independent of the test
macromolecules infused into the bloodstream; all experimental
results were therefore combined together (Table 1). Results
from three experiments were excluded, however, because of
catheters that were difficult to drain at the end of the experi-
ment. Indicator dilution estimates of dialysate volume in-
creased gradually with time throughout the four hour exchange.
The volume of dialysis solution determined by indicator dilution
at the end of the exchange was approximately twice the final
true volume. These results are similar to previous observations
from this laboratory [11, 20], and this discrepancy in volume
measurements is best explained by fluid absorption from the
peritoneal cavity at an average rate of 0.30 0.03 mI/mm (N =
24).
Plasma creatinine concentrations were similar when using
different test macromolecules and remained relatively constant
during each experimental exchange. The dialy sate creatinine
concentration increased with time during the four hour ex-
change, and the dialysate to plasma concentration ratio as a
function of time was independent of the test macromolecule
employed (Table 2). Moreover, the calculated values of PA for
creatinine when using neutral dextran, dextran sulfate and
DEAE dextran as test macromolecules were 2.49 0.38
ml/min, 2.09 0.34 mI/mm and 1.86 0.31 mLlmin, respec-
tively; these differences were not statistically significant. These
results demonstrate that transperitoneal transport of creatinine
was independent of the test macromolecule employed.
Fig. 1. The dialysate to plasma concentration ratio (C/C) at the end
of a four hour dwell plotted as afunction of molecular size for dextrans
with different charge. Symbols are: (— —) neutral dextran; (- - -)
dextran sulfate; (—) DEAE dextran. Coded lines connect each data
point, and error bars are shown only at selected data points.
The dependence of plasma and dialysate concentrations of
fluorescent-labeled dextrans on time paralleled those of creati-
nine except that dialysate concentrations relative to their
plasma values were considerably smaller. Figure 1 shows the
dependence of the dialysate to plasma concentration ratio
(Cd/CP) at the end of the exchange as a function of molecular
radius for dextrans with different charge. The results shown in
this figure were from experiments that did not employ unlabeled
dextrans. The dialysate to plasma concentration ratio at four
hours was not different for neutral dextran and dextran sulfate
at any molecular radius. The dialysate to plasma concentration
ratio at the end of the exchange was lower for DEAE dextran
than for neutral dextran with molecular radii between 19 and 22
A (P < 0.05) and anionic dextrans with molecular radii between
15 and 34 A (P < 0.05). Calculated values of PA are displayed
in Figure 2 as a function of molecular radius. Values of PA for
neutral dextran and DEAE dextran were different for molecular
radii between 27 and 40 A (P < 0.05). Moreover, calculated PA
values for dextran sulfate and DEAE dextran were different for
molecular radii between 20 and 29 A (P < 0.05). These results
demonstrate that transperitoneal transport of cationic dextran is
less than that for both neutral and anionic dextran.
For macromolecules of the size considered in this study,
transport rates during peritoneal dialysis are thought to be
governed largely by diffusion [11, 21]. (For macromolecules
with radii greater than approximately 40 A, however, convec-
tion has been proposed as the predominant transport mecha-
nism [22].) Figure 3 displays the calculated PA values shown in
the previous figure divided by the diffusion coefficient in free
solution (PAID) plotted as a function of molecular radius. The
diffusion coefficient in free solution for each test macromolecule
was calculated from its molecular radius calculated in equation
(1) [11]. This plot demonstrates that the dependence of PA/D on
Table 1. Dialysate volume measurements (mean SEM)
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Molecular radius, A
Fig. 2. The calculated value of peritoneal permeability-area product
(PA) plotted as a function of molecular size for dextrans with different
charge. Symbols are: (— . —) neutral dextran; (- - -) dextran sulfate;
(—) DEAE dextran. Coded lines connect each data point, and error
bars are shown only at selected data points.
Molecular radius, A
Fig. 4. The dialysate to plasma concentration ratio (CIC) at the end
of a four hour dwell plotted as a function of molecular size for neutral
dextran assessed with or without a fluorescent label. Symbols are: (—)
FITC labeled; (- --) FITC labeled (I); (—• —) unlabeled. The symbol(I) indicates that the FITC-labeled neutral dextran was first isolated
before being separated by chromatography. Coded lines connect each
data point, and error bars are shown only at selected data points.
Molecular radius, A
Fig. 3. The value of peritoneal permeability-area product divided by
the diffusion coefficient in free solution (PAID) plotted as a function of
molecular size for dextrans with different charge. Symbols are: (— —)
neutral dextran; (- - -)dextran sulfate; (—) DEAE dextran. Coded lines
connect each data point, and error bars are shown only at selected data
points.
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decreased with increasing molecular size, an indication of
hindered transperitoneal diffusion. These results therefore sug-
gest that the major peritoneal transport barrier to cationic
macromolecules may differ from that for neutral and anionic
macromolecules.
The results of additional in vivo experiments employing
different combinations of fluorescent-labeled and unlabeled
dextrans are shown in Figures 4 and 5. The results shown in
Figure 4 demonstrate that the dialysate to plasma concentration
ratio at the end of the exchange is the same for both FITC-
labeled and unlabeled forms of neutral dextran. Moreover, the
results for FITC-labeled neutral dextran were not dependent on
whether dextran was first isolated from the plasma and dialy-
sate samples before being separated by chromatography. Figure
5 displays PA values plotted as a function of molecular radius
for DTAF-labeled DEAE dextran. These results demonstrate
that transperitoneal transport of DTAF-labeled DEAE dextran
20 25 30 35 40 did not depend on prior filtration through an anionic exchange
column nor whether unlabeled DEAE dextran was simulta-
neously infused into the bloodstream. The observations shown
in Figures 4 and 5 suggest that the addition of the fluorescent
label to neutral and cationic dextrans does not significantly
influence their transport rate across the peritoneum. Moreover,
infusion of excess unlabeled DEAE dextran into the blood-
stream does not influence the transperitoneal transport rate for
DTAF-labeled DEAE dextran.
Further confirmation of the validity of the present chromato-
graphic methods was obtained by the results of the in vitro
experiments. Sieving coefficients for F60 hemodialyzers are
shown in Figure 6 as a function of molecular radius where
results for unlabeled neutral dextran, unlabeled DEAE dextran
molecular size for neutral and anionic dextrans was similar to
that for these macromolecules in free solution. Stated in other
words, transperitoneal diffusion of these macromolecules was
unhindered. In contrast, the values of PA/D for DEAE dextran
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Molecular radius, A
Fig. 5. The calculated value of peritoneal permeability-area product
(PA) plotted as a function of molecular size for DEAE dextran whether
the DTAF-labeled inacromolecule was infused into the bloodstream
either alone (—), after being filtered through an anionic exchange
column (— • —), or in the presence of excess unlabeled DEAE dextran
(- - -). Coded lines connect each data point, and error bars are shown
only at selected data points.
and DTAF-labeled DEAE dextran are compared. As reported
previously [23], addition of positive molecular charge does not
influence macromolecule sieving coefficients across this syn-
thetic membrane. Sieving coefficients for unlabeled and DTAF-
labeled DEAE dextran are indistinguishable. These results
provide important evidence confirming the validity of the
chromatographic methods for fluorescent-labeled dextrans per-
formed in the present study.
Discussion
Since the capillary wall is generally thought to be the primary
barrier governing macromolecule transport during peritoneal
dialysis, the major determinants of transcapillary and transperi-
toneal protein transport are likely similar. Indeed, previous
work has demonstrated that molecular size and transcapillary
(or transperitoneal) fluid movement are determinants of solute
transport both across the capillary wall and during peritoneal
dialysis [4, 5]. This similarity between transcapillary and
transperitoneal solute transport has recently been emphasized
by Rippe and Stelin [22], who have suggested that a three-pore
model of the capillary wall can adequately describe all relevant
aspects of transperitoneal solute transport.
The present study demonstrates that molecular charge is a
determinant of transperitoneal macromolecule transport and
should therefore be included in the list of common factors
governing both transcapillary and transperitoneal solute trans-
port. Molecular charge has previously been demonstrated to be
an important determinant of transcapillary macromolecule ex-
change in several different microcirculatory beds. Studies in rat
glomerular capillaries have clearly demonstrated the impor-
tance of molecular charge on glomerular transport of macro-
molecules [24, 25]. Within the glomerulus, anionic macromole-
cules were filtered less rapidly and cationic macromolecules
more rapidly than neutral macromolecules of identical molecu-
lar size. These observations have been explained by postulating
that the fixed negative charges on the glomerular capillary wall
inhibit the transport of anionic macromolecules and accelerate
the transport of cationic macromolecules by classic electro-
static interactions [26].
The effect of molecular charge on macromolecule transport in
other capillary beds has not, however, been studied as exten-
sively as in glomerular capillaries. Indeed, the results from such
studies are sometimes difficult to interpret. For example, cer-
tain studies have reported that reflection coefficients for anionic
macromolecules were greater (or capillary diffusive permeabil-
ities were lower) than for either neutral or cationic macromol-
ecules, observations that suggest more hindrance to transcap-
illary transport of anionic macromolecules. These results,
which are similar to those reported for the glomerular micro-
circulation, have been observed in tissues such as skin [27],
muscle [28, 29] and mesentery [30]. On the contrary, macro-
molecule transport studies in intestinal [31] and pulmonary [32]
capillary beds have found that lymph to plasma concentration
ratios (primarily a measure of capillary permeability) for cat-
ionic macromolecules were lower than for neutral or anionic
ones, observations that are opposite to those reported for
glomerular capillaries. These observations were not dependent
on the structure of the test macromolecules since both polymers
such as dextrans as well as proteins such as isozymes of lactate
dehydrogenase bearing different charges gave similar results.
These disparate observations were tentatively resolved by
suggesting that the capillary wall can be negatively charged in
some capillary beds but positive in others [31]. However,
ultrastructural studies using electron dense macromolecules to
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Fig. 6. Sieving coefficients plotted as a function of molecular size for
neutral dextran and DEAE dextran for the F60 hemodialyzer. Symbols
are: (—) unlabeled; (- - -) DTAF-labeled. Coded lines connect each data
point, and error bars are shown only at selected data points.
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locate and identify charged moieties on vascular endothelium
have observed a net negative charge on virtually all tissues that
have been examined [33, 34].
Parker and colleagues [32, 35] have extensively studied the
effect of molecular charge on macromolecule transport within
the pulmonary microcirculation and have suggested that the
electrochemical properties of the interstitium may be as impor-
tant as those of the capillary wall. They studied the transport of
two isozymes of lactate dehydrogenase with different molecular
charge by determining initial tissue clearance, steady state
lymph to plasma concentration ratios, and interstitial distribu-
tion volumes. Their data was most consistent with the hypoth-
esis that the negatively-charged interstitial tissue behaves as a
cation exchanger, facilitating the initial clearance of and creat-
ing a larger interstitial distribution volume for cationic macro-
molecules. They have hypothesized that the cation exchange
properties of interstitial tissue result from the binding of cat-
ionic macromolecules to the negatively-charged ground sub-
stance of the interstitial matrix. Their hypothesis appears
consistent with most previous work and provides an interesting
unifying hypothesis that would explain how a microcirculatory
bed could act as a positively-charged barrier yet still have a
negatively-charged vascular endothelium.
The results of the present study demonstrate that the perito-
neum exhibits macromolecule transport properties with respect
to molecular charge similar to those of the pulmonary micro-
circulation; that is, transport rates for cationic macromolecules
are less than those for either neutral or anionic macromole-
cules. The present observations are also consistent with the
general hypothesis of Parker, Gilchrist and Cartledge [32] since
the low transport rate for cationic macromolecules may be due
to their binding to interstitial tissue. Moreover, it is likely that
transperitoneal transport rates for neutral and anionic macro-
molecules are not different since neither can bind to the
negatively-charged components of interstitial tissue. Therefore,
the influence of molecular charge on macromolecule transport
during peritoneal dialysis is likely determined more by the
properties of peritoneal interstitial tissue than those of the
peritoneal capillary wall.
It should be emphasized that the present observations are
limited and do not permit a unique explanation for low
transperitoneal transport rates for cationic macromolecules
when compared with those for neutral and anionic macromol-
ecules of the same molecular size. Indeed, direct extrapolation
of these observations in a rabbit model using dextrans to protein
loss rates during peritoneal dialysis may not be valid. Certain in
vitro experiments have shown that neutral dextrans do not
always behave as ideal solid spheres. For example, recent
studies have shown that neutral dextrans diffuse more rapidly
across polycarbonate track-etch membranes than theoretical
predictions for solid spheres [36]. It is important to note,
however, that such nonideal behavior is not because the poly-
mers unravel and reptate through pores smaller than the Stokes
radius of the molecule itself [36]. Indeed, there is no evidence
that neutral dextrans can reptate through pores of the size range
studied here [37]. Furthermore, the present in vitro experiments
have demonstrated that the transport rates of neutral and
cationic dextrans across a neutral synthetic membrane are
equal. These observations suggest that differences in molecular
configuration between neutral and DEAE dextran are not
responsible for the present observations. A more complete
description of transperitoneal transport of charged macromole-
cules will require additional studies. The use of dextrans of
identical size but with different molecular charge will provide a
useful tool for these future investigations.
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